A novel and clinically feasible CO-therapy of deceased donor bone marrow combined with donor-matched mesenchymal stem cells to establish immune tolerance
Ended Project Grant Awarded Last action
- Award ID
- R43AI155196
- Recipient
-
Ossium Health, Inc. UEI FFNHJ2RDRHW3
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $584,920
Award facts
- Assistance listing
- 93.855 Allergy and Infectious Diseases Research
- Completion date
- Originally
- Funding
-
- $442,435.00 Federal
- $142,485.00 Non-federal
- Place of performance
- New Augusta, IN 46278, USA
Award details come from USAspending.gov.
Transactions
| Action | Federal | Non-federal | Date |
|---|---|---|---|
| Amendment | $0 | $0 | |
| Amendment | $142,485 | $0 | |
| Amendment | $142,485 | $142,485 | |
| Original award | $157,465 | $0 |
Quick answers
Who received award R43AI155196?
R43AI155196 was awarded to Ossium Health, Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on July 8, 2020.
How much is award R43AI155196 worth?
$584,920 has been obligated on R43AI155196: $442,435 in federal funding and $142,485 in non-federal funding.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award